Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78e50225d4743fe3e89ccc171fc35c12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca46e29bf7857d51b38ada93d6fd6faa |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2285 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
filingDate |
2007-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d6a1ad1e861b08160dfd8287bac5732 |
publicationDate |
2008-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2008075379-A1 |
titleOfInvention |
Novel formulation for enhanced delivery of diagnostic agents to tumor tissues |
abstract |
The invention describes an endothelin receptor based pharmaceutical formulation which can differential delivery of diagnostic agents to the tumor tissues particularly the solid tumors. The invention includes method of preparation, doses and mode of administering the formulation thereof. |
priorityDate |
2006-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |